1、APRIL 2023For Physicians and Pharma,Hybrid Engagement Is the New NormalPhysicians acceptance of virtual engagement increased during the pandemic,and their preference for face-to-face meetings is back to prepandemic levels Sources:Health care professionals biopharma surveys,May 2020(n=449);September

2、2020October 2020(n=591);May 2021June 2021(n=827);and June 2022July 2022(n=1,226);BCG analysis.Note:pp=percentage point.For the May 2020 survey,participants were asked to respond for two time periods:before and at the outset of COVID-19.Participants were asked,“What are your preferred tools for one-o

3、n-one or small-group personal engagement with pharmaceutical companies?”1Japans results were excluded since Japan was not included in the previous surveys.At the outset of COVID-19During COVID-19When COVID-19 vaccines were widely availableDuring the new normalBefore COVID-19Respondents preferred cha

4、nnels of engagement(%)16722141110221820174182314301828203442323162719252165330282125212826668302725252330158Participants were asked about their practice for five time periodsIn-person,face-to-face meetingScheduled webinar or webcastScheduled video chat(via FaceTime,Skype,or Zoom,for example)On-deman

5、d video chat(via FaceTime,Skype,or Zoom,for example)Scheduled callAd hoc callEmail conversationText conversation or chat app(such as WhatsApp)2PodcastCurrent acceptance of virtual channels is at least 5 pp higher than it was before COVID-1984While preferences vary by therapeutic area,84%of physician

6、s want to keep or increase the share of virtual interactions with pharma companiesSources:Health care professionals biopharma survey,June 2022July 2022(n=1,226);BCG analysis.Note:Participants responded to the statement,“Thinking about your current practice during the last two months,and thinking abo